↓ Skip to main content

The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1
Published in
Journal of Experimental & Clinical Cancer Research, January 2022
DOI 10.1186/s13046-022-02245-0
Pubmed ID
Authors

Jing Guo, Chuzhong Li, Qiuyue Fang, Yulou Liu, Dawei Wang, Yiyuan Chen, Weiyan Xie, Yazhuo Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 29%
Student > Master 2 14%
Student > Ph. D. Student 1 7%
Unspecified 1 7%
Student > Doctoral Student 1 7%
Other 1 7%
Unknown 4 29%
Readers by discipline Count As %
Medicine and Dentistry 3 21%
Biochemistry, Genetics and Molecular Biology 2 14%
Unspecified 1 7%
Veterinary Science and Veterinary Medicine 1 7%
Physics and Astronomy 1 7%
Other 3 21%
Unknown 3 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2022.
All research outputs
#8,541,797
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#574
of 2,383 outputs
Outputs of similar age
#184,109
of 515,259 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#25
of 88 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,259 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.